KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Net Cash Flow: 2009-2025

Historic Net Cash Flow for Cme Group (CME) over the last 16 years, with Sep 2025 value amounting to $7.3 billion.

  • Cme Group's Net Cash Flow fell 48.68% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 billion, marking a year-over-year increase of 304.52%. This contributed to the annual value of $8.7 billion for FY2024, which is 119.36% up from last year.
  • Per Cme Group's latest filing, its Net Cash Flow stood at $7.3 billion for Q3 2025, which was down 66.66% from $22.0 billion recorded in Q2 2025.
  • Cme Group's 5-year Net Cash Flow high stood at $36.0 billion for Q1 2021, and its period low was -$29.5 billion during Q2 2022.
  • Moreover, its 3-year median value for Net Cash Flow was $2.8 billion (2024), whereas its average is $1.2 billion.
  • Per our database at Business Quant, Cme Group's Net Cash Flow spiked by 11,356.97% in 2021 and then tumbled by 1,527.99% in 2023.
  • Cme Group's Net Cash Flow (Quarterly) stood at $10.1 billion in 2021, then crashed by 140.82% to -$4.1 billion in 2022, then soared by 187.35% to $3.6 billion in 2023, then plummeted by 99.76% to $8.5 million in 2024, then plummeted by 48.68% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q3 2025, $22.0 billion for Q2 2025, and $20.3 billion during Q1 2025.